Dr Reddys Laboratories Ltd Share Price Today - Live Blog for May 18, 2026

Dr Reddys Laboratories Ltd share price has declined by -0.45%, and it's currently trading at 1330.70. The stock maintains a PE of 26.8400, while the industry PE is 35.3588, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd shares experienced a -0.40% reduction, with the current market price at 1331.30. Investors are carefully considering their positions and seeking insights into the stock's future performance.

With a -0.40% decrease, Dr Reddys Laboratories Ltd's share price is currently at 1331.30. This development raises questions about the factors behind the decline. The stock's PE ratio is 26.8400, while the industry PE is 35.3588.

After a -0.26% decline, Dr Reddys Laboratories Ltd shares are now trading at 1333.20. The stock has a PE ratio of 26.8400, an ROE of 11.0737 and a debt to equity ratio of 0.2041.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.26%, reaching a current market price of 1333.20. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.10% drop, and it's now trading at 1335.40 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd witnessed a -0.10% drop in its share price and is currently trading at 1335.40. With the stock's PE at 26.8400 and the industry PE at 35.3588, investors are weighing their options.

Dr Reddys Laboratories Ltd share price has declined by -0.61%, and it's currently trading at 1328.50. The stock maintains a PE of 26.8400, while the industry PE is 35.3588, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd shares saw a -0.61% decrease, reaching a current market price of 1328.50. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 26.8400, an ROE of 11.0737 and a debt to equity ratio of 0.2041.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.28% in its share price, and it currently trades at 1332.90 per share. The stock has an ROE of 11.0737 and debt to equity ratio of 0.2041.

Dr Reddys Laboratories Ltd's share price has dropped by -0.28%, a development that warrants careful analysis. Presently trading at 1332.90, investors are assessing whether this presents an opportunity or a risk.